These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34081138)

  • 1. Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort.
    Vaculik K; Luu M; Howard LE; Aronson W; Terris M; Kane C; Amling C; Cooperberg M; Freedland SJ; Daskivich TJ
    JAMA Netw Open; 2021 Jun; 4(6):e2112214. PubMed ID: 34081138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of life expectancy on cost-effectiveness of treatment options for clinically localized prostate cancer.
    Naser-Tavakolian A; Venkataramana A; Spiegel B; Almario C; Kokorowski P; Freedland SJ; Anger JT; Leppert JT; Daskivich TJ
    Urol Oncol; 2023 Apr; 41(4):205.e1-205.e10. PubMed ID: 36737259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes.
    Wilt TJ; Cowper DC; Gammack JK; Going DR; Nugent S; Borowsky SJ
    Med Care; 1999 Oct; 37(10):1046-56. PubMed ID: 10524371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term overall survival of radical prostatectomy patients is often superior to the general population: A comparison using life-table data.
    Würnschimmel C; Wenzel M; Wang N; Tian Z; Karakiewicz PI; Graefen M; Huland H; Tilki D
    Prostate; 2021 Aug; 81(11):785-793. PubMed ID: 34101879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate Cancer.
    Daskivich TJ; Thomas IC; Luu M; Shelton JB; Makarov DV; Skolarus TA; Leppert JT
    J Urol; 2019 Sep; 202(3):518-524. PubMed ID: 31009286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing Trends in Surgical Management of Prostate Cancer: The End of Overtreatment?
    Huland H; Graefen M
    Eur Urol; 2015 Aug; 68(2):175-8. PubMed ID: 25736732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
    Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
    JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018.
    Parikh RB; Robinson KW; Chhatre S; Medvedeva E; Cashy JP; Veera S; Bauml JM; Fojo T; Navathe AS; Malkowicz SB; Mamtani R; Jayadevappa R
    JAMA Netw Open; 2020 Sep; 3(9):e2018318. PubMed ID: 32986109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy.
    Chen MS; Howard LE; Stock S; Dolgner A; Freedland SJ; Aronson W; Terris M; Klaassen Z; Kane C; Amling C; Cooperberg M; Daskivich TJ
    Prostate Cancer Prostatic Dis; 2023 Dec; 26(4):715-721. PubMed ID: 35668181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database.
    Ho T; Gerber L; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    Eur Urol; 2012 Nov; 62(5):910-6. PubMed ID: 22921964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Allott EH; Howard LE; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
    BJU Int; 2014 Nov; 114(5):661-6. PubMed ID: 24588774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database.
    Abern MR; Aronson WJ; Terris MK; Kane CJ; Presti JC; Amling CL; Freedland SJ
    Prostate; 2013 Mar; 73(4):409-17. PubMed ID: 22996686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomy.
    Simon RM; Howard LE; Moreira DM; Terris MK; Kane CJ; Aronson WJ; Amling CL; Cooperberg MR; Freedland SJ
    Int J Urol; 2017 Aug; 24(8):618-623. PubMed ID: 28697533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
    Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ
    Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy versus deferred treatment for localised prostate cancer.
    Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Trends in Prostate Biopsy and Radical Prostatectomy Volumes Following the US Preventive Services Task Force Guidelines Against Prostate-Specific Antigen Screening.
    Halpern JA; Shoag JE; Artis AS; Ballman KV; Sedrakyan A; Hershman DL; Wright JD; Shih YC; Hu JC
    JAMA Surg; 2017 Feb; 152(2):192-198. PubMed ID: 27806151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
    Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
    Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH database.
    Bañez LL; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Freedland SJ
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1208-12. PubMed ID: 19336564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
    Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort.
    Pereira V; Oyekunle T; Janes J; Amling CJ; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Klaassen Z; Freedland SJ; Vidal AC; Csizmadi I
    Prostate; 2023 Aug; 83(11):1011-1019. PubMed ID: 37096737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.